301024 Product Name: Ravulizumab
Filing date | Document type | Document Description | Number of pages | File Type | ||
---|---|---|---|---|---|---|
06/10/2020 | SPC Documents | Annex SPC | 18 | /2/2/9/7/9/0800497922/docs/301024_3_supplprotectioncertificate20201007090401208.pdf | ||
06/10/2020 | SPC Documents | Annex SPC | 41 | /2/2/9/7/9/0800497922/docs/301024_4_supplprotectioncertificate20201007090250916.pdf | ||
06/10/2020 | SPC Documents | Accompanying letter SPC | 16 | /2/2/9/7/9/0800497922/docs/301024_7_supplprotectioncertificate20201007090016763.pdf | ||
06/10/2020 | SPC Documents | Annex SPC | 30 | /2/2/9/7/9/0800497922/docs/301024_8_supplprotectioncertificate20201007090201048.pdf | ||
06/10/2020 | SPC Documents | Annex SPC | 1 | /2/2/9/7/9/0800497922/docs/301024_15_supplprotectioncertificate20201007090546730.pdf | ||
06/10/2020 | SPC Documents | Annex SPC | 4 | /2/2/9/7/9/0800497922/docs/301024_16_supplprotectioncertificate20201007090511654.pdf | ||
06/10/2020 | SPC Documents | Annex SPC | 6 | /2/2/9/7/9/0800497922/docs/301024_17_supplprotectioncertificate20201007090437972.pdf | ||
04/08/2020 | Outgoing Correspondence | Letter to applicant | 1 | /2/2/9/7/9/0800497922/docs/301024_19_358550l173.pdf | ||
03/08/2020 | SPC Documents | Accompanying letter SPC | 1 | /2/2/9/7/9/0800497922/docs/301024_0_supplprotectioncertificate20200804102458490.pdf | ||
07/05/2020 | Outgoing Correspondence | Letter to applicant | 3 | /2/2/9/7/9/0800497922/docs/301024_2_342944l173.pdf | ||
27/12/2019 | Outgoing Correspondence | Confirmation receipt request | 1 | /2/2/9/7/9/0800497922/docs/301024_18_317747l174.pdf | ||
20/12/2019 | Incoming Correspondence Paper | Other | 128 | /2/2/9/7/9/0800497922/docs/301024_1_incomingcorrespondencepaper20200106110327461.pdf | ||
20/12/2019 | SPC Documents | Summary of the characteristics of the product | 15 | /2/2/9/7/9/0800497922/docs/301024_5_supplprotectioncertificate20191224115732413.pdf | ||
20/12/2019 | SPC Documents | Annex SPC | 2 | /2/2/9/7/9/0800497922/docs/301024_6_supplprotectioncertificate20191224115732598.pdf | ||
20/12/2019 | Application Form | First filed application form | 2 | /2/2/9/7/9/0800497922/docs/301024_9_applicationform20191224115732065.pdf | ||
20/12/2019 | SPC Documents | Annex SPC | 14 | /2/2/9/7/9/0800497922/docs/301024_10_supplprotectioncertificate20191224115732533.pdf | ||
20/12/2019 | Incoming Correspondence Paper | Other | 19 | /2/2/9/7/9/0800497922/docs/301024_11_incomingcorrespondencepaper20200106111039734.pdf | ||
20/12/2019 | Incoming Correspondence Paper | Other | 143 | /2/2/9/7/9/0800497922/docs/301024_12_incomingcorrespondencepaper20200106110242149.pdf | ||
20/12/2019 | SPC Documents | Marketing Authorization SPC | 3 | /2/2/9/7/9/0800497922/docs/301024_13_supplprotectioncertificate20191224115732353.pdf | ||
20/12/2019 | SPC Documents | Annex SPC | 5 | /2/2/9/7/9/0800497922/docs/301024_14_supplprotectioncertificate20191224115732473.pdf | ||
20/12/2019 | Incoming Correspondence Paper | Other | 15 | /2/2/9/7/9/0800497922/docs/301024_20_incomingcorrespondencepaper20200106110639966.pdf | ||
20/12/2019 | Incoming Correspondence Paper | Accompanying letter incoming document | 3 | /2/2/9/7/9/0800497922/docs/301024_21_incomingcorrespondencepaper20191224115732229.pdf |